• Traceable against the WHO 2nd International Standard for Human IgE 75/502
  • Well correlated to the market leader
  • Continuously growing panel
  • Fully automated

An automated assay for the quantitative determination of Specific IgE in human serum on the IDS System. The results are to be used as an aid in the diagnosis and management of allergic disorders in conjunction with other clinical findings. The presence of allergen-specific IgE antibodies in serum is referred to as sensitisation and is an important risk factor for allergic reactions upon re-exposure to the allergen (1).

Associated allergen:

  • T216 rBet v 2 – Betula verrucosa

Adverse reactions to latex include non-allergic contact dermatitis, delayed type IV and immediate type I hypersensitivity (IgE-mediated). Type I hypersensitivity is the most serious response to latex proteins occurring minutes to hours after exposure and ranging from mild irritation to loss of life (2).

Bet v 2 is a minor allergen from Birch pollen and a pan allergen that is present in other pollen, plant food and latex.

  1. Hamilton RG. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. J Allergy Clin Immunol. 2014 Aug;134(2):360-1
  2. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250
  • IDS Total IgE / Specific IgE Reagent Kit
  • IDS Total IgE Control Set
  • IDS Positive and Negative Specific IgE Controls